Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 39Specimen Handling 36Carboplatin 34Bevacizumab 32pembrolizumab 31Magnetic Resonance Spectroscopy 29olaparib 19Cisplatin 16Biopsy 16liposomal doxorubicin 15Gemcitabine 14Taxes 12Nivolumab 12Immunoglobulin G 11Disulfides 11Topotecan 10Cyclophosphamide 10Doxorubicin 9fludarabine 8niraparib 7mirvetuximab soravtansine 7durvalumab 6Megestrol Acetate 6trastuzumab deruxtecan 5palbociclib 5Surveys and Questionnaires 5Radiation 5Oxaliplatin 5Fulvestrant 5Fluorouracil 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
human papillomavirus vaccine, TA × Gynecologic × 30 days × Clear all
NCT06315257 2026-05-20

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
32 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡